
Shirley V. Gembeh
Examiner (ID: 11999, Phone: (571)272-8504 , Office: P/1628 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1628, 1615, 1614, 1618 |
| Total Applications | 2053 |
| Issued Applications | 1120 |
| Pending Applications | 147 |
| Abandoned Applications | 807 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19209616
[patent_doc_number] => 11998654
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-04
[patent_title] => Securing implants and medical devices
[patent_app_type] => utility
[patent_app_number] => 16/508356
[patent_app_country] => US
[patent_app_date] => 2019-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4055
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16508356
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/508356 | Securing implants and medical devices | Jul 10, 2019 | Issued |
Array
(
[id] => 15290499
[patent_doc_number] => 20190388385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => METHODS FOR THE TREATMENT OF MAST CELL RELATED DISORDERS WITH MAST CELL STABILIZERS
[patent_app_type] => utility
[patent_app_number] => 16/508019
[patent_app_country] => US
[patent_app_date] => 2019-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59464
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16508019
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/508019 | METHODS FOR THE TREATMENT OF MAST CELL RELATED DISORDERS WITH MAST CELL STABILIZERS | Jul 9, 2019 | Abandoned |
Array
(
[id] => 16548871
[patent_doc_number] => 10882012
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => Process for producing a nano resveratrol microemulsion system
[patent_app_type] => utility
[patent_app_number] => 16/505692
[patent_app_country] => US
[patent_app_date] => 2019-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2578
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 303
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16505692
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/505692 | Process for producing a nano resveratrol microemulsion system | Jul 7, 2019 | Issued |
Array
(
[id] => 16899098
[patent_doc_number] => 20210178014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => ENDOSCOPE HEMOSTATIC MATERIAL
[patent_app_type] => utility
[patent_app_number] => 17/257500
[patent_app_country] => US
[patent_app_date] => 2019-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6549
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257500
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/257500 | ENDOSCOPE HEMOSTATIC MATERIAL | Jul 3, 2019 | Abandoned |
Array
(
[id] => 16335508
[patent_doc_number] => 10786445
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-29
[patent_title] => Methods of intravenous administration of glyburide
[patent_app_type] => utility
[patent_app_number] => 16/459893
[patent_app_country] => US
[patent_app_date] => 2019-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9202
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16459893
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/459893 | Methods of intravenous administration of glyburide | Jul 1, 2019 | Issued |
Array
(
[id] => 15828349
[patent_doc_number] => 20200129456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => THERAPY FOR KINASE-DEPENDENT MALIGNANCIES
[patent_app_type] => utility
[patent_app_number] => 16/456453
[patent_app_country] => US
[patent_app_date] => 2019-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26945
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16456453
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/456453 | THERAPY FOR KINASE-DEPENDENT MALIGNANCIES | Jun 27, 2019 | Abandoned |
Array
(
[id] => 15321025
[patent_doc_number] => 20200000842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => COMPOSITION AND METHOD FOR IMPROVING QOL WITH MOLECULAR HYDROGEN IN CANCER- HAVING SUBJECT
[patent_app_type] => utility
[patent_app_number] => 16/456085
[patent_app_country] => US
[patent_app_date] => 2019-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4700
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16456085
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/456085 | COMPOSITION AND METHOD FOR IMPROVING QOL WITH MOLECULAR HYDROGEN IN CANCER- HAVING SUBJECT | Jun 27, 2019 | Abandoned |
Array
(
[id] => 15034777
[patent_doc_number] => 20190328393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => IMPLANTABLE NERVE GUIDANCE CONDUITS HAVING POLYMER FIBER GUIDANCE CHANNEL
[patent_app_type] => utility
[patent_app_number] => 16/448550
[patent_app_country] => US
[patent_app_date] => 2019-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8989
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16448550
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/448550 | Implantable nerve guidance conduits having polymer fiber guidance channel | Jun 20, 2019 | Issued |
Array
(
[id] => 15290455
[patent_doc_number] => 20190388363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => SUSTAINED-RELEASE PREPARATION CONTAINING PSEUDOEPHEDRINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/447240
[patent_app_country] => US
[patent_app_date] => 2019-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3413
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16447240
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/447240 | Sustained-release preparation containing pseudoephedrine or a pharmaceutically acceptable salt thereof | Jun 19, 2019 | Issued |
Array
(
[id] => 15263207
[patent_doc_number] => 20190380337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => MICELLAR DELIVERY METHOD
[patent_app_type] => utility
[patent_app_number] => 16/445950
[patent_app_country] => US
[patent_app_date] => 2019-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8210
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16445950
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/445950 | MICELLAR DELIVERY METHOD | Jun 18, 2019 | Abandoned |
Array
(
[id] => 14990481
[patent_doc_number] => 20190314198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => Topical Ocular Delivery Methods and Devices for Use in the Same
[patent_app_type] => utility
[patent_app_number] => 16/444912
[patent_app_country] => US
[patent_app_date] => 2019-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22940
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16444912
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/444912 | Topical Ocular Delivery Methods and Devices for Use in the Same | Jun 17, 2019 | Abandoned |
Array
(
[id] => 18558714
[patent_doc_number] => 11723939
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-15
[patent_title] => Composition for gastric and oesophageal diseases
[patent_app_type] => utility
[patent_app_number] => 17/253756
[patent_app_country] => US
[patent_app_date] => 2019-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4046
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17253756
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/253756 | Composition for gastric and oesophageal diseases | Jun 16, 2019 | Issued |
Array
(
[id] => 19535547
[patent_doc_number] => 12128080
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-29
[patent_title] => Electrospun fibers containing nanodispersions and their use for the treatment of wounds
[patent_app_type] => utility
[patent_app_number] => 17/254373
[patent_app_country] => US
[patent_app_date] => 2019-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4806
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17254373
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/254373 | Electrospun fibers containing nanodispersions and their use for the treatment of wounds | Jun 16, 2019 | Issued |
Array
(
[id] => 15708455
[patent_doc_number] => 20200100993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => USE OF REVITALIZING COSMETIC COMPOSITION AND NON-THERAPEUTIC METHODS
[patent_app_type] => utility
[patent_app_number] => 16/442095
[patent_app_country] => US
[patent_app_date] => 2019-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16442095
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/442095 | USE OF REVITALIZING COSMETIC COMPOSITION AND NON-THERAPEUTIC METHODS | Jun 13, 2019 | Abandoned |
Array
(
[id] => 15342379
[patent_doc_number] => 20200009081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => Delivery Of Esketamine For The Treatment Of Depression
[patent_app_type] => utility
[patent_app_number] => 16/440570
[patent_app_country] => US
[patent_app_date] => 2019-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 122338
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16440570
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/440570 | Delivery Of Esketamine For The Treatment Of Depression | Jun 12, 2019 | Abandoned |
Array
(
[id] => 15323899
[patent_doc_number] => 20200002279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => INHIBITORS OF EGFR AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/440803
[patent_app_country] => US
[patent_app_date] => 2019-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16440803
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/440803 | Inhibitors of EGFR and methods of use thereof | Jun 12, 2019 | Issued |
Array
(
[id] => 15360829
[patent_doc_number] => 20200016179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
[patent_app_type] => utility
[patent_app_number] => 16/438972
[patent_app_country] => US
[patent_app_date] => 2019-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33587
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 301
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16438972
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/438972 | Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses | Jun 11, 2019 | Abandoned |
Array
(
[id] => 16351754
[patent_doc_number] => 10792244
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-06
[patent_title] => Parenteral sustained-release delivery of carvedilol disperse systems
[patent_app_type] => utility
[patent_app_number] => 16/429693
[patent_app_country] => US
[patent_app_date] => 2019-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 5
[patent_no_of_words] => 7678
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16429693
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/429693 | Parenteral sustained-release delivery of carvedilol disperse systems | Jun 2, 2019 | Issued |
Array
(
[id] => 16246062
[patent_doc_number] => 10745403
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-18
[patent_title] => Compositions, uses and methods for making them
[patent_app_type] => utility
[patent_app_number] => 16/430129
[patent_app_country] => US
[patent_app_date] => 2019-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27712
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 601
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16430129
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/430129 | Compositions, uses and methods for making them | Jun 2, 2019 | Issued |
Array
(
[id] => 19667375
[patent_doc_number] => 12180101
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-31
[patent_title] => Reducing compositions and processes for producing the same
[patent_app_type] => utility
[patent_app_number] => 15/733840
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 17624
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15733840
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/733840 | Reducing compositions and processes for producing the same | May 30, 2019 | Issued |